Trials / Completed
CompletedNCT03933787
Neuropeptide Y and Sympathovagal Balance
Neuropeptide Y Function in the Sympathovagal Balance During an Ergometric Test in Healthy Volunteers
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- Eric Grouzmann · Academic / Other
- Sex
- Male
- Age
- 24 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
Neuropeptide Y (NPY) activates the sympathetic and vagal nervous systems through the Y1 and Y2 receptors. This double-blind placebo-controlled crossover study investigated the sympathovagal balance during three exercises on a cycloergometer in healthy volunteers treated with saxagliptin (DPP4 inhibitor).
Detailed description
Pharmacological studies indicate that NPY has a role as a co-transmitter associated with catecholamines to maintain cardiovascular homeostasis. The development of a selective and sensitive assay of NPY1-36 (vasoconstrictor) and NPY3-36 (vasodilator) by LC-MS/MS will confirm this modulating role of NPY in sympatho vagal balance in healthy young subjects. This project should lead to a better understanding of the contribution of NPY to exercise physiology through a double-blind randomized study using a DPP4 inhibitor (Saxagliptin) used for the treatment of type 2 diabetes, blocking the formation of NPY3-36 and thus enhancing the effect of NPY1-36. The interest of this study will be to find targets other than adrenergic receptors in the regulation of sympathetic and parasympathetic systems during exercise.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Saxagliptin 5mg | Randomised study: session 1 the volunteer will receive either saxagliptin or placebo. Session 2 the volunteer will receive the placebo or saxagliptin |
| DRUG | Placebo oral capsule | Randomised study: session 1 the volunteer will receive either saxagliptin or placebo. Session 2 the volunteer will receive the placebo or saxagliptin |
| OTHER | ergometric test in healthy volunteers | The volunteers will undergo an ergometric test in each session |
Timeline
- Start date
- 2018-06-05
- Primary completion
- 2018-07-18
- Completion
- 2019-04-15
- First posted
- 2019-05-01
- Last updated
- 2019-05-01
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT03933787. Inclusion in this directory is not an endorsement.